Literature DB >> 10973317

Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis.

G Sabatakos1, N A Sims, J Chen, K Aoki, M B Kelz, M Amling, Y Bouali, K Mukhopadhyay, K Ford, E J Nestler, R Baron.   

Abstract

Members of the AP-1 family of transcription factors participate in the regulation of bone cell proliferation and differentiation. We report here a potent AP-1-related regulator of osteoblast function: DeltaFosB, a naturally occurring truncated form of FosB that arises from alternative splicing of the fosB transcript and is expressed in osteoblasts. Overexpression of DeltaFosB in transgenic mice leads to increased bone formation throughout the skeleton and a continuous post-developmental increase in bone mass, leading to osteosclerosis. In contrast, DeltaFosB inhibits adipogenesis both in vivo and in vitro, and downregulates the expression of early markers of adipocyte differentiation. Because osteoblasts and adipocytes are thought to share a common precursor, it is concluded that DeltaFosB transcriptionally regulates osteoblastogenesis, possibly at the expense of adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973317     DOI: 10.1038/79683

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  106 in total

1.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation.

Authors:  Sunhwa Kim; Takako Koga; Miho Isobe; Britt E Kern; Taeko Yokochi; Y Eugene Chin; Gerard Karsenty; Tadatsugu Taniguchi; Hiroshi Takayanagi
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

2.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 3.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 4.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene.

Authors:  Omar Akhouayri; Isabelle Quélo; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation.

Authors:  Keizo Nishikawa; Tomoki Nakashima; Shu Takeda; Masashi Isogai; Michito Hamada; Ayako Kimura; Tatsuhiko Kodama; Akira Yamaguchi; Michael J Owen; Satoru Takahashi; Hiroshi Takayanagi
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

7.  Alternative splicing in bone following mechanical loading.

Authors:  Sara M Mantila Roosa; Yunlong Liu; Charles H Turner
Journal:  Bone       Date:  2010-11-21       Impact factor: 4.398

8.  Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice.

Authors:  Mortaza Bonyadi; Stephen D Waldman; Danmei Liu; Jane E Aubin; Marc D Grynpas; William L Stanford
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 9.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

10.  Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARγ and hypoxia.

Authors:  J Luther; K Ubieta; N Hannemann; M Jimenez; M Garcia; C Zech; G Schett; E F Wagner; A Bozec
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.